Sibylla Biotech Competitors and Similar CompaniesClear all
Sibylla Biotech's competitors and similar companies include Cingulate and e-therapeutics.
 Cingulate Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety. | |||
Founding Date | Founding Date 2017 | Founding Date 2021 | Founding Date 2003 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Verona, IT HQ | Locations Kansas City, US HQ Morristown, US | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB |
Employees | Employees 383% decrease | Employees 13 | Employees 58 |
Financial | |||
Net income | Net income N/A | Net income ($22.4m) (FY, 2025) | Net income (£14.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 22.5m | Total funding raised N/A | Total funding raised $ 66.8m |
For sources of this data, please see the company profile
View Company Profiles
Cingulate
HQ
Kansas City, US
Employees
13
Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety.
View company
e-therapeutics
HQ
Long Hanborough, GB
Employees
58
e-therapeutics is a computational drug discovery company.
View company